Match!
Journal of Psychopharmacology
IF
4.22
Papers
3686
Papers 3718
1 page of 372 pages (3,718 results)
Newest
Background:Activation of the glutamate N-methyl-D-aspartate receptor with its co-agonist D-serine has been shown to improve subjective mood in healthy volunteers. D-alanine is another potent N-meth...
Source
#1Cristian Bernabe (IU: Indiana University)H-Index: 3
#2Izabela F Caliman (IU: Indiana University)
Last. Philip L. F. Johnson (IU: Indiana University)H-Index: 41
view all 8 authors...
Background:The central serotonergic system originating from the dorsal raphe nucleus (DR) plays a critical role in anxiety and trauma-related disorders such as posttraumatic stress disorder. Althou...
Source
Introduction and objectives:The ability to adapt to new task demands flexibly and to stabilise performance in the presence of distractors is termed cognitive control and is mediated by dopaminergic...
Source
#1Sophie E ter Hark (UU: Utrecht University)
#2Stéphane Jamain (French Institute of Health and Medical Research)H-Index: 16
Last. Sinan Guloksuz (Yale University)H-Index: 17
view all 15 authors...
Background:Antipsychotic-induced weight gain is a common and debilitating side effect of antipsychotics. Although genome-wide association studies of antipsychotic-induced weight gain have been perf...
Source
#1S. Scott Sutton (USC: University of South Carolina)H-Index: 8
#2Joseph Magagnoli (USC: University of South Carolina)H-Index: 2
Last. Bryan L. Love (USC: University of South Carolina)H-Index: 8
view all 5 authors...
Background:Ras-related C3 botulinum substrate 1 (Rac1) is a member of the small molecule family Rho guanosine triphosphate (GTP)ases. Recent findings reveal epigenetic downregulation of Rac1 is a m...
Source
#1Chun-Hung Chang (PRC: China Medical University (PRC))H-Index: 4
#2Chieh-Hsin Lin (PRC: China Medical University (PRC))H-Index: 12
Last. Hsien-Yuan LaneH-Index: 34
view all 5 authors...
Background:Sarcosine (N-methylglycine), a type 1 glycine transporter inhibitor (GlyT1), has shown therapeutic potential for treating schizophrenia; however, studies have reported conflicting result...
Source
#1Ehsan Mozen-Zadeh (Tehran University of Medical Sciences)
#2Samaneh Bayanati (Tehran University of Medical Sciences)
Last. Shahin Akhondzadeh (Tehran University of Medical Sciences)H-Index: 47
view all 6 authors...
Introduction and objectives:Vortioxetine, a novel antidepressant, may be an interesting candidate for adjunctive therapy of schizophrenia. Our primary objective was to investigate the effect of vor...
Source
#1Paul Glue (University of Otago)H-Index: 27
#2Shona Neehoff (University of Otago)H-Index: 4
Last. Natalie J. Medlicott (University of Otago)H-Index: 12
view all 8 authors...
Background:We previously reported that ketamine has anxiolytic effects in patients with treatment-resistant generalized anxiety and social anxiety disorders.Aims:The purpose of this study was to re...
Source
#1Sean B. Dolan (JHUSOM: Johns Hopkins University School of Medicine)
#2Meredith S. Berry (UF: University of Florida)H-Index: 3
Last. Matthew W. Johnson (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 37
view all 4 authors...
Background:There has been growing interest in using oxytocin as a pharmacotherapy for psychiatric disorders, including substance use disorder. Limited data exist regarding oxytocin’s reinforcing ef...
Source
#1Clemens MuehlanH-Index: 3
#2Margaux BoehlerH-Index: 2
Last. Jasper DingemanseH-Index: 34
view all 6 authors...
Background:The dual orexin receptor antagonist ACT-541468 showed sedative pharmacodynamic effects during initial clinical testing in adult subjects. The present study explored pharmacokinetics, pha...
Source
12345678910
Top fields of study
Psychiatry
Endocrinology
Psychology
Anesthesia
Schizophrenia
Pharmacology